A Sneak Peek At Cantel Medical Corp. ($CMD) 4Q20 Earnings

Cantel Medical Corp. (NYSE:CMD) is reporting fourth quarter earnings results on Thursday 17th September 2020, before market open.

The consensus estimates from Thomson Reuters are loss of $ 0.01 per share.

For the full year, analysts predict revenues of $ 1007.79 million, while looking forward to income of $ 1.36 per share.

The Company Outlook

Revenue for 4Q20 are expected in a range of $ 230.00 million ~ $ 235.00 million

Full Year 2020 topline are forecasted in a range of$ 1,148.00 million ~ $ 1,175.00 million, where as bottomline are predicted in a range of $ 2.58 ~ $ 2.61 per share

Click Here For More Historical Outlooks Of Cantel Medical Corp.

Previous Quarter Performance

Cantel Medical Corp. came out with income for the third quarter of $ 0.16 per share, from the revenue of $ 236.93 million. The quarterly earnings reduced 70.91 percent compared with the same quarter last year. The consensus estimates are income of $ 0.37 per share from $ 242.63 million in revenue. The bottom line results missed street analysts by $ 0.21 or 56.76 percent, at the same time, top line results fell short of analysts by $ 5.7 million or 2.35 percent.

Stock Performance

Shares of Cantel Medical Corp. traded low $ -1.16 or -2.31 percent on Wednesday, reaching $ 49.10 with volume of 310.50 thousand shares. Cantel Medical Corp. has traded high as $ 50.87 and has cracked $ 48.95 on the downward trend

According to the previous trading day, closing price of $ 49.10, representing a 141.52 % increase from the 52 week low of $ 20.81 and a 44.64 % decrease over the 52 week high of $ 90.79.

The company has a market capital of $ 2.07 billion and is part of the Healthcare sector and Medical Instruments & Supplies industry.

Recent Analyst recommendations

  • On 19th August 2020, initiated by Bank of America at Underperform rating, with $ 51.00 target price.
Conference Call

Cantel Medical Corp. will be hosting a conference call at 8:30 AM eastern time on 17th September 2020, to discuss its 4Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.cantelmedical.com

Cantel Medical Corp. provides infection prevention and control products and services for the healthcare market. The companys Endoscopy segment offers automated endoscope reprocessing systems; infectants and sterilants; detergents; leak testing and manual cleaning products; storage cabinets, transport systems, and mobile medical carts; manual cleaning products; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid endoscopes, flexible endoscopes, and other instrumentation; and technical maintenance services.